Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer’s disease

by Patrizia eGiannoni, Patrizia eGiannoni, Patrizia eGiannoni, Florence eGaven, Florence eGaven, Florence eGaven, Dimitri eDe Bundel, Dimitri eDe Bundel, Dimitri eDe Bundel, Kevin eBaranger, Kevin eBaranger, Kevin eBaranger, Evelyne eMarchetti-Gauthier, Evelyne eMarchetti-Gauthier, François S Roman, François S Roman, Emmanuel eValjent, Emmanuel eValjent, Emmanuel eValjent, Philippe eMarin, Philippe eMarin, Philippe eMarin, Joël eBockaert, Joël eBockaert, Joël eBockaert, Santiago eRivera, Santiago eRivera, Santiago eRivera, Sylvie eClaeysen, Sylvie eClaeysen, Sylvie eClaeysen
Published 2013-12-01